BioNTech Delivery Technologies GmbH
2 more in force are now held by other companies
Held is read from USPTO's recorded assignments; a transfer never recorded there does not appear.
7
Ending by 2030
Jul 2028
Next term end
When these terms end
Held patents by the year their term ends
20262027202820292030203120322033203420352036203720382039204020412042204320442045
Fee deadlines
Maintenance fees fall due 3.5, 7.5 and 11.5 years after grant. A missed fee ends a patent at the end of the six month grace period that follows, not on the due date.
- 1 fee due Dec 30, 2026The maintenance fee for Amphoteric liposomes (US 9,066,867) comes due Dec 30, 2026. Unpaid by Jun 30, 2027, it lapses early.
- 1 fee due Sep 15, 2027The maintenance fee for Amphoteric Liposomes, A Method Of Formulating An Amphoteric Liposome And A Method Of Loading An Amphoteric Liposome (US 9,283,186) comes due Sep 15, 2027. Unpaid by Mar 15, 2028, it lapses early.
Recent changes
- 1 term has ended since Aug 17, 2026
Patents held now
Soonest term end first. Each date below is computed on that patent's own page, which shows the rule, the adjustments and the fee history it was derived from.
Showing 1 to 10 of 10
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 8,367,628 | Amphoteric Liposome Formulation In force · Medium confidence | In force | Medium confidence | |
| US 8,193,246 | Lipids and Lipid Assemblies Comprising Transfection Enhancer Elements In force · Medium confidence | In force | Medium confidence | |
| US 9,066,867 | Amphoteric liposomes In force · Medium confidence | In force | Medium confidence | |
| US 9,283,186 | Amphoteric Liposomes, A Method Of Formulating An Amphoteric Liposome And A Method Of Loading An Amphoteric Liposome In force · Medium confidence | In force | Medium confidence | |
| US 8,957,191 | Nucleic Acid Comprising Zwitterionic Nucleotides In force · High confidence | In force | High confidence | |
| US 10,039,714 | Imino compounds for amphoteric liposomes and uses thereof In force · From the USPTO record | In force | From the USPTO record | |
| US 11,541,010 | Amphoteric liposomes comprising imino lipids In force · From the USPTO record | In force | From the USPTO record | |
| US 9,677,073 | Hydroxylated polyamine derivatives as transfection reagents In force · From the USPTO record | In force | From the USPTO record | |
| US 9,677,078 | Carboxylated Polyamine Derivatives as Transfection Reagents In force · High confidence | In force | High confidence | |
| US 10,894,962 | Carboxylated 2′-amino-LNA nucleotides and oligonucleotides comprising the same In force · From the USPTO record | In force | From the USPTO record |
Also on record, not counted in the 10: 2 patents in force now held by others · 8 ended at full term. List them
Sources and methods
Compiled from the USPTO record, grants, published applications and recorded assignments, not yet reviewed by hand.
How this record was built
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.
Published applications
US patent applications published under this name that have not become patents. An application is published about eighteen months after its earliest filing; one that has not been published is in no public record.
2 pending